Trials / Completed
CompletedNCT04002466
Anemia Etiology Evaluation in Ethiopia
Evaluation of Dietary Iron Intake, Anemia, and Iron Status Among Men, Women, and Children in Ethiopia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,114 (actual)
- Sponsor
- Harvard School of Public Health (HSPH) · Academic / Other
- Sex
- All
- Age
- 6 Months – 48 Years
- Healthy volunteers
- Accepted
Summary
The AnemEE study is a population-based anemia etiology survey in six regions of Ethiopia. The primary aim of the study is to evaluate the relative contribution of risk factors for anemia among children, women of reproductive age, and adult men. The study data are intended to inform evidence-based decision-making on anemia control interventions.
Detailed description
The AnemEE study is a population-based cross-sectional survey of children (6-59 months), adult women of reproductive age (15-49 years) and adult males (15-49 years) in six regions of Ethiopia (Afar, Amhara, Tigray, Oromia, Southern Nations, Nationalities and Peoples' Region and Addis Ababa). The study will enroll approximately 5,100 participants and will be conducted in two survey rounds; one survey round in the Belg season and one survey round in the Meher season. All participants will have hemoglobin assessed and will have standardized questionnaires administered to assess sociodemographic, diet, morbidity, and other health/nutrition factors. All participants will also have assessments of anthropometric measures, malaria, and soil transmitted helminth infection. A subset of participants will also have serum ferritin, CRP, AGP, vitamin B12, and folate concentrations assessed. The study data will be used to determine the relative contributions of risk factors for anemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Risk factors for anemia | Diet, iron, vitamin B12, folate, inflammation, soil transmitted helminth infection, malaria, other morbidities and other health/nutrition/sociodemographic factors |
Timeline
- Start date
- 2019-01-27
- Primary completion
- 2019-08-15
- Completion
- 2019-08-15
- First posted
- 2019-06-28
- Last updated
- 2020-07-28
Locations
1 site across 1 country: Ethiopia
Source: ClinicalTrials.gov record NCT04002466. Inclusion in this directory is not an endorsement.